A 3D-pharmacophore model for sigma2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.

In this work we developed a 3D-pharmacophore model for sigma(2) receptor based on 19 benzooxazolone derivatives. The best 3D-pharmacophore hypothesis, consisting of five features: a positive ionizable, a hydrogen bond acceptor, a hydrophobic aromatic, a hydrophobic aliphatic, and a generic hydrophobic provided a 3D-QSAR model with a correlation coefficient of 0.97 and a RMSD of 0.48.

[1]  R. Mach,et al.  Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. , 1997, Cancer research.

[2]  V. Ganapathy,et al.  Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). , 1996, Biochemical and biophysical research communications.

[3]  P. Acton,et al.  Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent. , 2001, Nuclear medicine and biology.

[4]  Maurizio Fermeglia,et al.  Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. , 2009, Journal of medicinal chemistry.

[5]  M. Friebe,et al.  [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma. , 2001, Journal of medicinal chemistry.

[6]  J. I.  The Design of Experiments , 1936, Nature.

[7]  P. Willett,et al.  PHARMACOPHORE PERCEPTION , DEVELOPMENT , AND USE IN DRUG DESIGN , 2011 .

[8]  R. Glennon,et al.  Structural features important for sigma 1 receptor binding. , 1994, Journal of medicinal chemistry.

[9]  F. Berardi,et al.  Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer. , 2006, Cancer letters.

[10]  R. Matsumoto.  Sigma Receptors: Chemistry, Cell Biology And Clinical Implications , 2007 .

[11]  W. Bowen.  Sigma receptors: recent advances and new clinical potentials. , 2000, Pharmaceutica acta Helvetiae.

[12]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Thierry Langer,et al.  Discovery of high-affinity ligands of σ1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening , 2005 .

[14]  D. Rossi,et al.  Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site. , 2009, European journal of medicinal chemistry.

[15]  X. Codony,et al.  Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.

[16]  W. Bowen,et al.  Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling , 1994 .

[17]  F. Berardi,et al.  Antiproliferative and cytotoxic effects of some σ2 agonists and σ1 antagonists in tumour cell lines , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  W. Bowen,et al.  A proposal for the classification of sigma binding sites. , 1992, Trends in pharmacological sciences.

[19]  Osman F. Güner,et al.  Pharmacophore perception, development, and use in drug design , 2000 .

[20]  A. Bossuyt,et al.  Labelled sigma receptor ligands: can their role in neurology and oncology be extended? , 2001, European Journal of Nuclear Medicine.